La Jolla Pharmaceutical Company
COMPOSITIONS AND METHODS FOR TREATING RENAL FAILURE
Last updated:
Abstract:
The present disclosure relates to the use of angiotensin II in therapeutic methods for the treatment of renal failure, especially renal failure associated with cirrhosis.
Status:
Application
Type:
Utility
Filling date:
30 Jul 2021
Issue date:
23 Jun 2022